|
White blood cell count (per μL)
|
4000–11,000
|
5200
|
|
Hemoglobin (g/dL)
|
14.0–18.0
|
13.0
|
|
Mean corpuscular volume (fL)
|
82–98
|
87
|
|
Platelet count (per μL)
|
140,000–440,000
|
208,000
|
|
Sodium (mEq/L)
|
136–145
|
143
|
|
Blood urea nitrogen (mg/dL)
|
8–20
|
16
|
|
Creatinine (mg/dL)
|
0.70–1.30
|
1.19
|
|
Lactate dehydrogenase (U/L)
|
313–618
|
870
|
|
Hepatitis A IgM antibody
|
Negative
|
Negative
|
|
Hepatitis B surface antigen
|
Non-reactive
|
Non-reactive
|
|
Hepatitis B surface antibody (mIU/mL)
|
< 5.0 (Negative)
|
< 5.0 (Negative)
|
|
Hepatitis B total core antibody
|
Non-reactive
|
Non-reactive
|
|
Hepatitis B DNA (IU/mL)
|
Undetected
|
Undetected
|
|
Hepatitis C antibody
|
Non-reactive
|
Non-reactive
|
|
Hepatitis E IgM antibody
|
Negative
|
Negative
|
|
Hepatitis E IgG antibody
|
Negative
|
Positive
|
|
CMV IgM (units)
|
0.0–0.9
|
0.9 (Equivocal)
|
|
CMV IgG (units)
|
0.00–0.79
|
11.90
|
|
EBV viral capsid antigen IgM antibody
|
Negative
|
Negative
|
|
EBV viral capsid antigen IgG antibody
|
Negative
|
Positive
|
|
EBV nuclear antigen IgG antibody
|
Negative
|
Positive
|
|
HSV-1 DNA (copies/mL)
|
Not detected
|
Not detected
|
|
HSV-2 DNA (copies/mL)
|
Not detected
|
Not detected
|
|
Anti-nuclear antibody titer
|
< 1:40
|
< 1:40
|
|
Anti-smooth muscle antibody
|
Negative
|
Negative
|
|
Anti-mitochondrial antibody
|
Negative
|
Negative
|
|
Anti-liver kidney microsomal type 1 antibody
|
Negative
|
Negative
|
|
Ceruloplasmin (mg/dL)
|
19.0–31.0
|
30.5
|
|
Ferritin (ng/mL)
|
30–400
|
638
|
|
Iron (μg/dL)
|
49–181
|
51
|
|
Total iron binding capacity (μg/dL)
|
250.0–450.0
|
247.7
|
|
HFE gene mutation analysis
|
–
|
One copy of H63D detected
|
|
Triglycerides (mg/dL)
|
< 150
|
166b
|
|
LDL-cholesterol (mg/dL)
|
< 100
|
74b
|
|
Anti-tissue transglutaminase IgA antibody (U/mL)
|
< 4.0
|
< 1.2
|
|
Anti-tissue transglutaminase IgG antibody (U/mL)
|
< 6.0
|
< 1.2
|
